DE69632405D1 - 5-0-desosaminyl 6-0-methyl erythronolid a, ihre verfahren zur herstellung und ihre verwendung zur herstellung ein arzneimittel - Google Patents

5-0-desosaminyl 6-0-methyl erythronolid a, ihre verfahren zur herstellung und ihre verwendung zur herstellung ein arzneimittel

Info

Publication number
DE69632405D1
DE69632405D1 DE69632405T DE69632405T DE69632405D1 DE 69632405 D1 DE69632405 D1 DE 69632405D1 DE 69632405 T DE69632405 T DE 69632405T DE 69632405 T DE69632405 T DE 69632405T DE 69632405 D1 DE69632405 D1 DE 69632405D1
Authority
DE
Germany
Prior art keywords
production
desosaminyl
medicinal product
methyl erythronolide
erythronolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69632405T
Other languages
English (en)
Other versions
DE69632405T2 (de
Inventor
Alain Bonnet
Michel Delthil
Alain Mazurie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69632405(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69632405D1 publication Critical patent/DE69632405D1/de
Application granted granted Critical
Publication of DE69632405T2 publication Critical patent/DE69632405T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69632405T 1995-09-11 1996-09-10 5-0-desosaminyl 6-0-methyl erythronolid a, ihre verfahren zur herstellung und ihre verwendung zur herstellung von arzneimitteln Expired - Lifetime DE69632405T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9510601A FR2738571B1 (fr) 1995-09-11 1995-09-11 Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
FR9510601 1995-09-11
PCT/FR1996/001384 WO1997010251A1 (fr) 1995-09-11 1996-09-10 Nouveaux derives de la 5-0-desosaminyl 6-0-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs

Publications (2)

Publication Number Publication Date
DE69632405D1 true DE69632405D1 (de) 2004-06-09
DE69632405T2 DE69632405T2 (de) 2005-05-19

Family

ID=9482423

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632405T Expired - Lifetime DE69632405T2 (de) 1995-09-11 1996-09-10 5-0-desosaminyl 6-0-methyl erythronolid a, ihre verfahren zur herstellung und ihre verwendung zur herstellung von arzneimitteln

Country Status (34)

Country Link
US (1) US5969161A (de)
EP (1) EP0854880B1 (de)
JP (1) JP4332218B2 (de)
KR (1) KR100457755B1 (de)
CN (2) CN1237069C (de)
AP (1) AP887A (de)
AR (1) AR004195A1 (de)
AT (1) ATE266035T1 (de)
AU (1) AU708811B2 (de)
BG (1) BG63822B1 (de)
BR (1) BR9610503A (de)
CA (1) CA2228670C (de)
CZ (3) CZ289945B6 (de)
DE (1) DE69632405T2 (de)
DK (1) DK0854880T3 (de)
EA (1) EA000575B1 (de)
EE (1) EE03774B1 (de)
ES (1) ES2219698T3 (de)
FR (1) FR2738571B1 (de)
GE (1) GEP20022838B (de)
HK (2) HK1016187A1 (de)
HU (1) HU227565B1 (de)
IL (1) IL123550A (de)
MX (1) MX9801859A (de)
NO (2) NO312678B1 (de)
PL (1) PL183652B1 (de)
PT (1) PT854880E (de)
RO (1) RO120137B1 (de)
SI (1) SI0854880T1 (de)
SK (3) SK283690B6 (de)
TR (1) TR199800438T1 (de)
UA (1) UA53628C2 (de)
WO (1) WO1997010251A1 (de)
ZA (1) ZA966837B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334274A (en) * 1996-09-04 2001-02-23 Abbott Lab 6-o-substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) * 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
AU2003219770B2 (en) * 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
CN1659178A (zh) * 2002-05-13 2005-08-24 英安塔制药有限公司 6、11二环红霉素衍生物
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
WO2005070918A1 (en) * 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
US7419962B2 (en) 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
TW200635600A (en) 2004-12-13 2006-10-16 Enanta Pharm Inc Tetracyclic bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
EP1907392A1 (de) * 2005-07-26 2008-04-09 Merckle Gmbh Makrolidkonjugate von pyrrolizin- und indolizinverbindungen als inhibitoren von 5-lipooxygenase und cyclooxygenase
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
EP2203435B1 (de) * 2007-09-17 2018-07-18 Enanta Pharmaceuticals, Inc. 6, 11-gebrückte biaryl-makrolide
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
CN103232501A (zh) * 2013-04-11 2013-08-07 宜昌东阳光药业股份有限公司 阿奇霉素或阿奇霉素的中间体脱去克拉定糖化合物的制备工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives

Also Published As

Publication number Publication date
AP887A (en) 2000-11-10
PT854880E (pt) 2004-09-30
EP0854880A1 (de) 1998-07-29
MX9801859A (es) 1998-11-30
BG63822B1 (bg) 2003-02-28
EA000575B1 (ru) 1999-12-29
CZ294865B6 (cs) 2005-04-13
NO315048B1 (no) 2003-06-30
BR9610503A (pt) 1999-07-06
CZ294866B6 (cs) 2005-04-13
HK1041489B (zh) 2006-09-08
ZA966837B (en) 1997-08-13
FR2738571A1 (fr) 1997-03-14
BG102312A (en) 1998-09-30
SK283690B6 (sk) 2003-12-02
HU227565B1 (en) 2011-08-29
JP4332218B2 (ja) 2009-09-16
SK285853B6 (sk) 2007-09-06
CN1237069C (zh) 2006-01-18
US5969161A (en) 1999-10-19
AP9801210A0 (en) 1998-03-31
HK1041489A1 (en) 2002-07-12
HUP9802930A3 (en) 1999-12-28
CN1319602A (zh) 2001-10-31
AU708811B2 (en) 1999-08-12
CA2228670C (fr) 2005-04-12
JPH11512416A (ja) 1999-10-26
SI0854880T1 (en) 2004-12-31
NO981053D0 (no) 1998-03-10
ATE266035T1 (de) 2004-05-15
AU6991096A (en) 1997-04-01
EE03774B1 (et) 2002-06-17
PL183652B1 (pl) 2002-06-28
KR19990044543A (ko) 1999-06-25
CZ289945B6 (cs) 2002-04-17
IL123550A0 (en) 1998-10-30
EE9800065A (et) 1998-08-17
CN1201462A (zh) 1998-12-09
TR199800438T1 (xx) 1998-05-21
UA53628C2 (uk) 2003-02-17
GEP20022838B (en) 2002-11-25
EP0854880B1 (de) 2004-05-06
SK285995B6 (sk) 2008-01-07
FR2738571B1 (fr) 1997-10-17
NO20021111L (no) 1998-03-10
HK1016187A1 (en) 1999-10-29
DE69632405T2 (de) 2005-05-19
CA2228670A1 (fr) 1997-03-20
CZ71798A3 (cs) 1998-07-15
HUP9802930A1 (hu) 1999-04-28
PL326274A1 (en) 1998-08-31
IL123550A (en) 2002-09-12
DK0854880T3 (da) 2004-08-16
SK29498A3 (en) 1998-12-02
NO981053L (no) 1998-03-10
KR100457755B1 (ko) 2005-02-28
AR004195A1 (es) 1998-11-04
CN1070498C (zh) 2001-09-05
ES2219698T3 (es) 2004-12-01
NO20021111D0 (no) 2002-03-06
NO312678B1 (no) 2002-06-17
EA199800288A1 (ru) 1998-08-27
RO120137B1 (ro) 2005-09-30
WO1997010251A1 (fr) 1997-03-20

Similar Documents

Publication Publication Date Title
DE69632405D1 (de) 5-0-desosaminyl 6-0-methyl erythronolid a, ihre verfahren zur herstellung und ihre verwendung zur herstellung ein arzneimittel
ATE172203T1 (de) Erythromycinderivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
ATE234853T1 (de) Erythromycin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel
DE69724142D1 (de) Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
DE69636303D1 (de) Monolithhaltematerial, verfahren zur herstellung, katalytischer konverter und verfahren zu dessen herstellung
ATE206131T1 (de) Phosphonomonoesternnukleinsäuren, verfahren zu ihrer herstellung und ihre verwendung
DE69131627D1 (de) Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
ATE217633T1 (de) Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
DE69432186D1 (de) Verfahren zur herstellung stabiler arzneimittel
DE69631943D1 (de) Substituierte camptothecinderivate und verfahren zur ihrer herstellung
DE69618607T2 (de) Derivate von 5-0-desosaminyl-6-0-methyl erythronolid a, ihre verfahren zur herstellung und verwendung zur herstellung von arzneimitteln
DE69626682T2 (de) Verfahren zur herstellung von guanidinderivaten, zwischenprodukte dafür und ihre herstellung
DE59610517D1 (de) Befestigungselement und Verfahren zu dessen Herstellung
DE59610963D1 (de) Neue phenylamidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69623319D1 (de) Milchprodukt und verfahren zu dessen herstellung
DE69604094D1 (de) Dichtungsprofil und Verfahren zu dessen Herstellung
ATE211911T1 (de) Tiagabinhydrochlorid enthaltendes arzneimittel und verfahren zu dessen herstellung
DE59604850D1 (de) Falzprodukt sowie verfahren und vorrichtung zu dessen herstellung
DE69716284T2 (de) Erythromycin-derivate, verfahren zur herstellung und verwendung als arzneimittel
ATE214364T1 (de) Iminooxyphenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung
DE69619863T2 (de) Verfahren zur herstellung von anti-malaria arzneimittel
DE69819340D1 (de) Optisch reine camptothecinanaloge, optisch reines synthese-zwischenprodukt und verfahren zu ihrer herstellung
DE19681518T1 (de) Nahrungsmittelprodukt und Verfahren zu dessen Herstellung
DE69521142T2 (de) 6-methoxy-1h-benzotriazol-5-carboxamid-derivate, verfahren zur herstellung und diese enthaltende arzneimittel
DE69609282D1 (de) Succinamid-Derivat, Verfahren zur Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC